17. Immunologic endocrine disorders

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 2 SUPPL. 2, 2003, Pages

  Devendra, Devasenan ^a   Eisenbarth, George S ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Addison's disease; APS 1; APS 2; Autoantibodies; Graves' disease; HLA; Polyendocrine autoimmunity; Premature ovarian failure; Type I diabetes; XPID syndrome

Indexed keywords

ANTITHYROID AGENT; AUTOANTIBODY; FLUDROCORTISONE; HLA ANTIGEN; HYDROCORTISONE; INSULIN; LIOTHYRONINE; RADIOACTIVE IODINE; THIAMAZOLE; THYROID HORMONE; THYROXINE; TRANSCRIPTION FACTOR;

ADDISON DISEASE; ANTIBODY SCREENING; AUTOIMMUNE DISEASE; AUTOIMMUNITY; DIABETES MELLITUS; ENDOCRINE DISEASE; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC SUSCEPTIBILITY; GRAVES DISEASE; HUMAN; HYPOPARATHYROIDISM; HYPOPHYSITIS; IMMUNOGENETICS; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; IMMUNOTHERAPY; INSULIN AUTOIMMUNE SYNDROME; INSULIN TREATMENT; METABOLIC DISORDER; MORBIDITY; MORTALITY; MULTIPLE ENDOCRINE ADENOMATOSIS; MULTIPLE SCLEROSIS; PARAPROTEINEMIA; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; REVIEW; THYROIDITIS; X LINKED AUTOIMMUNITY ALLERGIC SYNDROME;

EID: 0037328895     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.81     Document Type: Review

References (87)

1. American Diabetes Association, Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
2. Pugliese A, Eisenbarth GS. Type I Diabetes Mellitus of Man: Genetic Susceptibility and Resistance. Type I Diabetes: Molecular. Cell Clin Immunol [2]. 2002. Ref Type: Electronic Citation.
3. Atkinson MA, Eisenbarth GS. Type I Diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001;358:221-9.
4. Cox NJ, Wapelhorst B, Morrison VA, Johnson L, Pinchuk L, Spielman RS, et al. Seven regions of the genome show evidence of linkage to type I diabetes in a consensus analysis of 767 multiplex families. Am J Hum Genet 2001;69:820-30.
5. Bennett ST, Todd JA. Human type I diabetes and the insulin gene: principles of mapping polygenes. Annu Rev Genet 1996;30:343-70.
6. Pugliese A, Zeller M, Fernandez A, Zalcberg LJ, Bartlett RJ, Ricordi C, et al. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type I diabetes. Nat Genet 1997;15:293-7.
7. Pugliese A, Brown D, Garza D, Zeller M, Redondo MJ, Eisenbarth GS, et al. Self-antigen presenting cells expressing islet cell molecules in human thymus and peripheral lymphoid organs: phenotypic characterization and implications for immunological tolerance and type I diabetes. J Clin Invest 2001;107:555-64.
8. Nistico L, Buzzetti R, Pritchard LE, van der Auwera B, Giovannini C, Bosi E, et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type I diabetes. Belgian Diabetes Registry. Hum Mol Genet 1996;5:1075-80.
9. Bao F, Yu L, Babu S, Wang T, Hoffenberg EJ, Rewers M, et al. One third of HLA DQ2 homozygous patients with type I diabetes express celiac disease associated transglutaminase autoantibodies. J Autoimmun 1999;13:143-8.
10. Hoffenberg EJ, Bao F, Eisenbarth GS, Uhlhorn C, Haas J, Sokol RJ, et al. Transglutaminase antibodies in children with a genetic risk for celiac disease. J Pediatr 2000;137:356-60.
11. Williams AJ, Norcross AJ, Lock RJ, Unsworth DJ, Gale EA, Bingley PJ. The high prevalence of autoantibodies to tissue transglutaminase in first-degree relatives of patients with type I diabetes is not associated with islet autoimmunity. Diabetes Care 2001;24:504-9.
12. Brewer KW, Parziale VS, Eisenbarth GS. Screening patients with insulin-dependent diabetes mellitus for adrenal insufficiency. N Engl J Med 1997;337:202.
13. De Block CE, De LI, Van Gaal LF. High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type I (insulin-dependent) diabetic patients: the Belgian Diabetes Registry. J Clin Endocrinol Metab 1999;84:4062-7.
14. Gerstein HC. Incidence of postpartum thyroid dysfunction in patients with type I diabetes mellitus. Ann Intern Med 1993;118:419-23.
15. Macaron C, Winter RJ, Traisman HS, Kahan BD, Lasser AE, Green OC. Vitiligo and juvenile diabetes mellitus. Arch Dermatol 1977;113:1515-7.
16. Norris JM, Beaty B, Klingensmith G, Yu L, Hoffman M, Chase HP, et al. Lack of association between early exposure to cow's milk protein and b-cell autoimmunity: Diabetes Autoimmunity Study in the Young (DAISY). JAMA 1996;276:609-14.
17. Kimpimaki T, Erkkola M, Korhonen S, Kupila A, Virtanen SM, Ilonen J, et al. Short-term exclusive breastfeeding predisposes young children with increased genetic risk of Type I diabetes to progressive beta-cell autoimmunity. Diabetologia 2001;44:63-9.
18. Sadeharju K, Lonnrot M, Kimpimaki T, Savola K, Erkkila S, Kalliokoski T, et al. Enterovirus antibody levels during the first two years of life in prediabetic autoantibody-positive children. Diabetologia 2001;44:818-23.
19. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type I diabetes: a birth-cohort study. Lancet 2001;358:1500-3.
20. Murakami M, Iriuchijima T, Mori M. Diabetes mellitus and interferon-α therapy. Ann Intern Med 1995;123:318.
21. Moriyama H, Wen L, Abiru N, Liu E, Yu L, Miao D, et al. Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide. Proc Natl Acad Sci U S A 2002;99:5539-44.
22. Foulis AK, McGill M, Farquharson MA. Insulitis in type I (insulin-dependent) diabetes mellitus in man - macrophages, lymphocytes, and interferon-gamma containing cells. J Pathol 1991;165:97-103.
23. Martin S, Wolf-Eichbaum D, Duinkerken G, Scherbaum WA, Kolb H, Noordzij JG, et al. Development of type I diabetes despite severe hereditary B-lymphocyte deficiency. N Engl J Med 2001;345:1036-40.
24. Moriwaki M, Itoh N, Miyagawa J, Yamamoto K, Imagawa A, Yamagata K, et al. Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus. Diabetologia 1999;42:1332-40.
25. Nerup J, Mandrup-Poulsen T, Helqvist S, Andersen HU, Pociot F, Reimers JI, et al. On the pathogenesis of IDDM. [Review]. Diabetologia 1994;37(Suppl 2):S82-9.
26. Herskowitz RD, Wolfsdorf JI, Ricker AT, Vardi P, Dib S, Soeldner JS, et al. Transient hyperglycemia in childhood: identification of a subgroup with imminent diabetes mellitus. Diabetes Res 1988;9:161-7.
27. Chase HP, Dolan LM, Krischer JP, White N, Wolfsdorf JI, Cuthbertson DD, et al. First phase insulin release during the intravenous glucose tolerance test as a risk factor for type I diabetes. J Pediatr 2001;138:244-9.
28. Garg SK, Anderson JH, Perry SV, Mackenzie T, Keith P, Jennings MK, et al. Long-term efficacy of humalog in subjects with Type I diabetes mellitus. Diabet Med 1999;16:384-7.
29. Mastrototaro JJ. The MiniMed continuous glucose monitoring system. Diabetes Technol Ther 2000;2(Suppl 1):S13-8.
30. Garg SK, Potts RO, Ackerman NR, Fermi SJ, Tamada JA, Chase HP. Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type I diabetes. Diabetes Care 1999;22:1708-14.
31. Assan R, Feutren G, Debray-Sachs M, Quiniou-Debrie M, Laborie C, Thomas G, et al. Metabolic and immunological effects of cyclosporine in recently Type I diabetes mellitus. Lancet 1985;1:67-71.
32. Stiller CR, Dupre J, Gent M, Jenner MR, Keown PA, Laupacis A, et al. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 1984;223:1362-7.
33. Dyrberg T, Nakhooda AF, Baekkeskov S, Lernmark Å, Poussier P, Marliss EB. Islet cell surface antibodies and lymphocyte antibodies in the spontaneously diabetic BB Wistar rat. Diabetologia 1982;31:278-81.
34. Blasi C, Pierelli F, Rispoli E, Saponara M, Vingolo E, Andreani D. Wolfram's syndrome: a clinical, diagnostic, and interpretative contribution. Diabetes Care 1986;9:521-8.
35. Ryan EA, Lakey JRT, Rajotte RV, Korbutt GS, Kin T, Imes S, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton Protocol. Diabetologia 2001;50:710-9.
36. Uchigata Y, Hirata Y. Insulin Autoimmune Syndrome (IAS, Hirata Disease). In: Eisenbarth G, editor. Molecular mechanisms of endocrine and organ specific autoimmunity. Austin, Tex: RG Landes: 1999. p. 133-48.
37. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM. The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocrinol Rev 1998;19:673-716.
38. Chen QY, Huang W, She JX, Baxter F, Volpe R, Maclaren NK. HLA-DRB 1*08. DRB 1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective. J Clin Endocrinol Metab 1999;84:3182-6.
39. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF. International Consortium for the Genetics of Autoimmune Thyroid Disease. Linkage analysis of candidate genes in autoimmune thyroid disease. III: detailed analysis of chromosome 14 localizes Graves' disease-1 (GD-1) close to multimodular goiter-1 (MNG-1). J Clin Endocrinol Metab 1998;83:4321-7.
40. Barbesino G, Tomer Y, Concepcion ES, Davies TF, Greenberg DA. Linkage analysis of candidate genes in autoimmune thyroid disease. II: selected gender-related genes and the X-chromosome: International Consortium for the Genetics of Autoimmune Thyroid Disease. J Clin Endocrinol Metab 1998;83:3290-5.
41. Geuder KI, Marx A, Witzemann V, Schalke B, Kirchner T, Müller-Hermelink HK. Genomic organization and lack of transcription of the nicotinic acetylcholine receptor subunit genes in myasthenia gravis-associated thymoma. Lab Invest 1992;452:458.
42. Weetman AP. Graves' disease. N Engl J Med 2000;343:1236-48.
43. Gillis D, Volpe R, Daneman D. A young boy with a thyroid yo-yo. J Pediatr Endocrinol Metab 1998;11:467-70.
44. Flier JS, Kahn CR, Roth J, Bar RS. Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science 1975;190:63-5.
45. Martin A, Nakashima M, Zhou A, Aronson D, Werner AJ, Davies TF. Detection of major T cell epitopes on human thyroid stimulating hormone receptor by overriding immune heterogeneity in patients with Graves' disease. J Clin Endocrinol Metab 1997;82:3361-6.
46. Coles AJ, Wing M, Smith S, Coraddu F, Greer S, Taylor C, et al. Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 1999;354:1691-5.
47. Bahn RS, Dutton CM, Natt N, Joba W, Spitzweg C, Heufelder AE. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy. J Clin Endocrinol Metab 1998;83:998-1002.
48. Many MC, Costagliola S, Detrait M, Denef F, Vassart G, Ludgate MC. Development of an animal model of autoimmune thyroid eye disease. J Immunol 1999;162:4966-74.
49. Bartalena L, Bogazzi F, Tanda ML, Manetti L, Dell'Unto E, Martino E. Cigarette smoking and the thyroid. Eur J Endocrinol 1995;133:507-12.
50. Davies TF, Roti E, Braverman LE, DeGroot LJ. Thyroid controversy: stimulating antibodies. J Clin Endocrinol Metab 1998;83:3777-85.
51. Zakarija M, Mckenzie JM, Eidson MS. Transient neonatal hypothyroidism: characterization of maternal antibodies to the thyrotropin receptor. J Clin Endocrinol Metab 1990;70:1239-46.
52. Leech NJ, Dayan CM. Controversies in the management of Graves' disease. Clin Endocrinol (Oxf) 1998;49:273-80.
53. Kloos RT. Thyroiditis. In: Robert ER, editor. Conn's current therapy. Philadelphia, Pa: WB Saunders Co; 2002. p. 634-41.
54. Park Y, She J-X, Babu S, Wang T, Noble JA, Erlich H, et al. Transracial evidence for the influence of the homologous HLA DR-DQ haplotype on transmission of HLA DR4 haplotypes to diabetic children. Tissue Antigens 2001;57:185-91.
55. Mine H, Kawai H, Yokoi K, Akaike M, Saito S. High frequencies of human T-lymphotropic virus type I (HTLV-I) infection and presence of HTLV-II proviral DNA in blood donors with anti-thyroid antibodies. J Mol Med 1996;74:471-7.
56. Endo T, Kogai T, Nakazato M, Saito T, Kaneshige M, Onaya T. Autoantibody against Na+/I- symporter in the sera of patients with autoimmune thyroid disease. Biochem Biophys Res Commun 1996;224:92-5.
57. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ, Jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 1999;340:424-9.
58. Arafah BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med 2001;344:1743-9.
59. Sommers SC. Adrenal glands. In: Kissane JM, editor. Anderson's pathology. St Louis, Mo: CV Mosby; 2002. p. 1429-50.
60. Baker JR Jr. Autoimmune endocrine disease. JAMA 1997;278:1931-7.
61. Falorni A, Nikoshkov A, Laureti S, Grenbäck E, Hulting A-L, Casucci G, et al. High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab 1995;80:2752-5.
62. Yu L, Brewer KW, Gates S, Wang T, Babu S, Gottlieb PA, et al. DRB1*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease. J Clin Endocrinol Metab 1999;84:328-35.
63. Myhre AG, Undlien DE, Lovas K, Uhlving S, Nedrebo BG, Kristian JF, et al. Autoimmune adrenocortical failure in Norway: autoantibodies and HLA class II associations related to clinical features. J Clin Endocrinol Metab 2002;87:618-23.
64. Gambelunghe G, Falorni A, Ghaderi M, Laureti S, Tortoioli C, Santeusanio F, et al. Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease. J Clin Endocrinol Metab 1999;84:3701-7.
65. Neufeld M, Maclaren N, Blizzard R. Autoimmune polyglandular syndromes. Pediatr Ann 1980;9:154-62.
66. Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis: ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990;322:1829-36.
67. Betterle C, Caretto A, Zeviani M, Pedini B, Salviati C. Demonstration and characterization of anti-human mitochondria autoantibodies in idiopathic hypoparathyroidism and in other conditions. Clin Exp Immunol 1985;62:353-60.
68. Posillico JT, Wortsman J, Srikanta S, Eisenbarth GS, Malette LE, Brown EM. Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells. Bone Miner Res 1986;1:475-83.
69. Rebar RW, Connolly HV. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril 1990;53:804-10.
70. LaBarbera AR, Miller MM, Ober C, Rebar RW. Autoimmune etiology in premature ovarian failure. Am J Reprod Immunol Microbiol 1988;16:115-22.
71. Betterle C, Scalici C, Presotto F, Pedini B, Moro L, Rigon F, et al. The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. J Endocrinol 1988;117:467-75.
72. Sobrinho-Simoes M, Brandao A, Paiva ME, Vilela B, Fernandes E, Carneiro-Chaves F. Lymphoid hypophysitis in a patient with lymphoid thyroiditis, lymphoid adrenalitis, and idiopathic retroperitoneal fibrosis. Arch Pathol Lab Med 1985;109:230-3.
73. Pestell RG, Best JD, Alford FP. Lymphocytic hypophysitis: the clinical spectrum of the disorder and evidence for an autoimmune pathogenesis. Clin Endocrinol (Oxf) 1990;33:457-66.
74. Ozawa Y, Shishiba Y. Recovery from lymphocytic hypophysitis associated with painless thyroiditis: clinical implications of circulating antipituitary antibodies. Acta Endocrinol (Copenh) 1993;128:493-8.
75. Thodou E, Asa SL, Kontogeorgos G, Kovacs K, Horvath E, Ezzat K. Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings. J Clin Endocrinol Metab 1995;80:2302-11.
76. Butler MG, Hodes ME, Conneally PM, Biegel AA, Wright JC. Linkage analysis in a large kindred with autosomal dominant transmission of polyglandular autoimmune disease type II (Schmidt syndrome). Am J Med Genet 1984;18:61-5.
77. Thorpe ES, Handley HE. Chronic tetany and chronic mycelial stomatitis in a child aged four-and-one-half years. Am J Dis Child 1929;38:328-38.
78. Leonard MF. Chronic idiopathic hypoprathyroidism with superimposed Addison's disease in a child. J Clin Endocrinol Metab 1946;6:493-5.
79. Whitaker J, Landing BH, Esselborn VM, William RR. The syndrome of familial juvenile hypoadrenocorticism, hypoparathyroidism and superficial moniliasis. J Endocrinol 1956;16:1374-87.
80. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, et al. Positional cloning of the APECED gene. Nat Genet 1997;17:393-8.
81. Halonen M, Eskelin P, Myhre AG, Perheentupa J, Husebye ES, Kampe O, et al. AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. J Clin Endocrinol Metab 2002;87:2568-74.
82. Maes M, Eisenbarth GS. The polyglandular autoimmune syndromes. In: Volpé R, editor. Contemporary endocrinology on autoimmune endocrinopathies. Totowa: Humana Press Inc; 1999. p. 349-63.
83. Donner H, Braun J, Seidl C, Rau H, Finke R, Ventz M, et al. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocrinol Metab 1997;82:4130-2.
84. Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, et al. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type-1 diabetes mellitus. J Clin Endocrinol Metab 1997;82:143-6.
85. Petersen JS, Hejnaes KR, Moody A, Karlsen AE, Marshall MO, Hoier-Madsen M, et al. Detection of GAD65 antibodies in Diabetes and other autoimmune diseases: using a simple radioligand assay. Diabetologia 1994;43:459-67.
86. De Bellis AA, Falorni A, Laureti S, Perrino S, Coronella C, Forini F, et al. Time course of 21-hydroxylase antibodies and long-term remission of subclinical autoimmune adrenalitis after corticosteroid therapy: case report. J Clin Endocrinol Metab 2001;86:675-8.
87. Rovira M, Carreras E, Blade J, Graus F, Valls J, Fernandez-Aviles F, et al. Dramatic improvement of POEMS syndrome following autologous haematopoietic cell transplantation. Br J Haematol 2001;115:373-5.